Quick Answer
Ovid Therapeutics Inc. reported Total Revenue of $7.25 million for fiscal year 2025.
Ovid Therapeutics Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $7.25M | +1181.3% |
| 2024 | $566.0K | +44.4% |
| 2023 | $392.0K | -73.9% |
| 2022 | $1.50M | -99.3% |
| 2021 | $208.38M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $132.0K | -23.7% | -97.9% |
| June 30, 2025 | $6.27M | +3611.2% | +4724.6% |
| March 31, 2025 | $130.0K | -12.2% | -24.9% |
| September 30, 2024 | $173.0K | +58.7% | +2.4% |
| June 30, 2024 | $169.0K | +125.3% | +14.2% |
| March 31, 2024 | $148.0K | +124.2% | +35.8% |
| September 30, 2023 | $109.0K | +881.8% | +45.3% |
| June 30, 2023 | $75.0K | — | +13.6% |
- Ovid Therapeutics Inc. showed an increase of +1181.3% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2025 period, Ovid Therapeutics Inc.’s total revenue has declined by 96.5% (from $208.38 million to $7.25 million).
- The most recent figure is from Ovid Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: